GH Research (GHRS) Accumulated Expenses (2020 - 2025)

GH Research's (GHRS) quarterly Accumulated Expenses came in at $3.3 million in Q4 2025, down 13.65% year-on-year from $3.9 million in Q4 2024, and down 13.65% quarter-over-quarter from $3.9 million in Q4 2024.

GH Research (GHRS) Accumulated Expenses (2020 - 2025) Analysis & Trends

GH Research's Accumulated Expenses history runs 6 years deep, the most recent figure standing at $3.3 million for Q4 2025.

  • On a quarterly basis, Accumulated Expenses fell 13.65% year-over-year to $3.3 million in Q4 2025; TTM through Dec 2025 was $3.3 million, a 13.65% decrease from a year earlier, with the FY2025 full-year figure at $3.3 million, down 13.65% from the prior year.
  • Accumulated Expenses slipped to $3.3 million in Q4 2025 per GHRS's latest filing, from $3.9 million in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $3.9 million in Q4 2024 and bottomed at $1.7 million in Q4 2021.
  • The 5-year median for Accumulated Expenses is $2.4 million (2022), against an average of $2.7 million.
  • Across the five-year window, Accumulated Expenses surged 601.65% in 2021 and slipped 13.65% in 2025, its largest moves.
  • Year by year, Accumulated Expenses stood at $1.7 million in 2021, then soared by 39.34% to $2.4 million in 2022, then dropped by 1.73% to $2.3 million in 2023, then jumped by 66.37% to $3.9 million in 2024, then retreated by 13.65% to $3.3 million in 2025.
  • Per Business Quant, the three latest GHRS Accumulated Expenses figures stand at $3.3 million (Q4 2025), $3.9 million (Q4 2024), and $2.3 million (Q4 2023).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 GH Research 1.69 Bn 1.69 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2025 3.34 Mn
Dec 31, 2024 3.87 Mn
Dec 31, 2023 2.33 Mn
Dec 31, 2022 2.37 Mn
Dec 31, 2021 1.70 Mn
Dec 31, 2020 242,000.00